Mandate

Vinge advises Bergs Timber in connection with its in kind acquisition of Norvik’s timber operations in the Baltics and the United Kingdom.

June 28, 2018 Banking and Finance

Vinge has advised Bergs Timber AB (publ) (”Bergs Timber”) on legal matters in connection with its acquisition of Norvik hf’s (“Norvik”) timber operations in the Baltics and the United Kingdom.

The acquisition of Norvik’s timber operations in the Baltics and the United was approved by the extraordinary shareholders’ meeting in Bergs Timber held on May 14, 2018. The acquisition was made by an issue in kind where the contribution consisted of 170 million shares in Bergs Timber as well as a cash payment of SEK 270 million, amounting to a calculated value of approximately SEK 719 million as per April 17, 2018. The newly issued shares were admitted to trading on Nasdaq Stockholm, Small Cap, on June 7, 2018.

Through the acquisition, Bergs Timber will become a significant participant within the sawmill market, as its sawmill capacity increases from approximately 530,000 m³ per year to approximately 920,000 m³ per year. The acquisition will also increase Bergs Timber’s product processing and thus has the capacity of limiting Bergs Timber’s sensitivity to fluctuations in the economic cycle. The group’s raw materials base is also broadened while risks are spread as part of the production is based on costs in euro.

Vinge’s team primarily consisted of Jesper Schönbeck, Ulrich Ziche, Joel Wahlberg, Sabina Börjesson, Maria Dahlin, Johanna Wiberg, Ramin Baradaran, Pauline Lagerstrand, Boris Kotur, Vilhelm Rondahl and Fredric Reissmüller.
 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026